1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsStation 41 Therapeutics Accelerator 2025 RFP is sponsored by Southern Research’s Station 41 Therapeutics Accelerator. Seeks proposals from investigators within the University of Alabama at Birmingham to advance new drug, biologic, or diagnostic products.
Get alerted about grants like this
Get emailed when new opportunities from “Southern Research’s Station 41 Therapeutics Accelerator” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Investigators within the University of Alabama at Birmingham. Confirm the full requirements in the official notice before applying.
Station 41 Therapeutics Accelerator 2025 RFP is funded by Southern Research’s Station 41 Therapeutics Accelerator. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Alabama. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The EDA's May 11 NOFO will award 5-8 grants of $1M-$8M for AI workforce training — but only to employer-led sectoral partnerships, not standalone training providers. With a 60% federal cap and a 24-36 month performance period, the design favors regional coalitions over universities. Here is how to assemble a winning application.
Read articleThe Strategic Breakthrough Awards mechanism authorized in the February 2026 SBIR reauthorization is the first post-Phase II funding instrument in program history. The mandatory 100 percent private match and the four-year performance window reposition SBIR from research subsidy to commercialization accelerator — and small businesses that do not understand that pivot will fail to compete for the first solicitations in Q4.
Read articleDOE's Critical Minerals and Materials Accelerator funds lithium extraction, rare earth recycling, and semiconductor-grade refining. Staggered deadlines run through July 2026.
Read article